Gastrointestinal cancer educational case series: management of metastatic adenocarcinoma of unknown primary origin in a Ph+ ALL survivor. (Q51530091)

6 April 2018

title

Gastrointestinal cancer educational case series: management of metastatic adenocarcinoma of unknown primary origin in a Ph+ ALL survivor. (English)

1 reference

6 April 2018

metastatic adenocarcinoma

main subject

1 reference

Maeve Lowery

8

0 references

author name string

Celina Ang

1

1 reference

6 April 2018

Eileen M O'Reilly

2

1 reference

6 April 2018

Ghassan K Abou-Alfa

3

1 reference

6 April 2018

Ali Shamseddine

4

1 reference

6 April 2018

Hadi Skouri

5

1 reference

6 April 2018

Ayman Tawil

6

1 reference

6 April 2018

Mohamad A Eloubeidi

7

1 reference

6 April 2018

Mohamed Kharfan-Dabaja

9

1 reference

6 April 2018

Tania Kaprealian

10

1 reference

6 April 2018

Sally Temraz

11

1 reference

6 April 2018

Hassan Sibai

12

1 reference

6 April 2018

Hassan Farran

13

1 reference

6 April 2018

Manish A Shah

14

1 reference

6 April 2018

publication date

1 September 2011

1 reference

6 April 2018

Journal of gastrointestinal cancer

published in

1 reference

6 April 2018

volume

42

1 reference

6 April 2018

issue

3

1 reference

6 April 2018

page(s)

165-170

1 reference

6 April 2018

https://scigraph.springernature.com/pub.10.1007/s12029-010-9233-1

exact match

0 references

cites work

Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9233-1

Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9233-1

Are survivors of acute lymphoblastic leukemia (ALL) at increased risk of cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9233-1

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9233-1

Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9233-1

MicroRNAs in cancer: small molecules with a huge impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9233-1

Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9233-1

FDG PET/CT in carcinoma of unknown primary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9233-1

Hepatocellular carcinoma in two patients with cardiac cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9233-1

Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9233-1

Treatment for patients with unknown primary carcinoma and unfavorable prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12029-010-9233-1

Therapy of adenocarcinoma of unknown primary: are we making progress?

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21128012

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12029-010-9233-1

1 reference

6 April 2018

PubMed ID

21128012

1 reference

6 April 2018